0 Σχόλια
0 Μοιράστηκε
504 Views
0 Προεπισκόπηση
Προωθημένο
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
From Prenatal Testing to Oncology: Noninvasive Technology AdvancesThe Noninvasive Cancer Diagnostics Market, valued at approximately USD 5.8 billion in 2024, is projected to reach around USD 15.3 billion by 2031, representing a robust 16.2% compound annual growth rate through 2025–2031. This surge is fueled by technological advances in liquid biopsies, AI enabled imaging, and an increasing volume of early cancer screening across clinical channels....0 Σχόλια 0 Μοιράστηκε 494 Views 0 Προεπισκόπηση
-
Global Trends in Injectable Cytotoxic Oncology DrugsWhat is the projected growth rate (CAGR) of the Injectable Cytotoxic Drugs Market from 2024 to 2031, and what is the market value expected to change by 2031? The Global Injectable Cytotoxic Drugs Market reached US$13.12 billion in 2024 and is expected to reach US$20.59 billion by 2032, growing at a CAGR of 5.2% during the forecast period 2025-2032. What is the Injectable Cytotoxic Drugs...0 Σχόλια 0 Μοιράστηκε 246 Views 0 Προεπισκόπηση
-
Head and Neck Oncology Pipeline: Immunotherapy and Targeted AgentsWhat is the projected growth rate (CAGR) of the Head and Neck Cancer Pipeline Insights 2025, and what is the market value expected to change by 2033? The Global Head and Neck Cancer Market is projected to reach a significant value by 2033, growing at a promising CAGR during the forecast period. What is Head and Neck Cancer Pipeline Insights 2025? Head and neck cancer refers to a group of...0 Σχόλια 0 Μοιράστηκε 301 Views 0 Προεπισκόπηση
-
Japan Pioneers Radiotheranostics in Geriatric Oncology CareThe global theranostics market reached USD 1.8 billion in 2022 and is projected to grow to USD 4.2 billion by 2031, exhibiting a CAGR of 11.3% during the forecast period 2024–2031, driven by rising demand for personalized and precise medical treatments. Theranostics combines diagnostics and targeted therapy to tailor care based on individual disease profiles, leveraging molecular and...0 Σχόλια 0 Μοιράστηκε 715 Views 0 Προεπισκόπηση
-
mRNA Vaccine Market Insights: Oncology, Infectious Disease, and InnovationWhat is the projected growth rate (CAGR) of the mRNA Vaccines Market from 2024 to 2031, and what is the market value expected to change by 2031? mRNA Vaccines and Therapeutics market size reached US$410 Million in 2024 and is expected to reach US$850.90 Million by 2033, growing at a CAGR of 8.5% during the forecast period 2025-2033. What is the mRNA Vaccines Market? The mRNA Vaccines Market...0 Σχόλια 0 Μοιράστηκε 205 Views 0 Προεπισκόπηση
-
Oncology and Cardiovascular Therapies Lead API Demand SurgeThe global Active Pharmaceutical Ingredients (API) market is projected to grow from USD 236.6 billion in 2023 to USD 370.7 billion by 2031, registering a compound annual growth rate (CAGR) of 5.8% over the forecast period. This growth is driven by the rising prevalence of chronic diseases, increasing demand for generic and biologic drugs, and the global expansion of pharmaceutical...0 Σχόλια 0 Μοιράστηκε 394 Views 0 Προεπισκόπηση
-
Precision Oncology Boosts Monoclonal Antibodies MarketGlobal Cancer Monoclonal Antibodies Market Soars with 14%+ CAGR, US and Japan Lead Innovation The Cancer Monoclonal Antibodies (mAbs) market sector is undergoing a major transformation, fueled by rapid advancements in biotechnology and a rising demand for targeted cancer therapies. Monoclonal antibodies have emerged as one of the most promising modalities in oncology, offering highly specific...0 Σχόλια 0 Μοιράστηκε 538 Views 0 Προεπισκόπηση
-
Radioligand Therapy Revolution: CI Insights into the Future of Precision OncologyRadioligand therapy (RLT) combines tumor-specific ligands with radioisotopes to deliver highly targeted radiation to cancer cells with minimal impact on healthy tissues. Founded on a precision innovation model in hemophilia B, RLT is transforming the treatment of metastatic and refractory cancers. With recent clinical approvals and an expanding global pipeline, RLT promises sustained innovation...0 Σχόλια 0 Μοιράστηκε 410 Views 0 Προεπισκόπηση
-
Revolutionizing Oncology: HER2 Low Cancers Market Insights and Strategic OpportunitiesThe oncology landscape is witnessing a transformative shift as researchers and pharmaceutical companies increasingly focus on HER2-low breast cancers, a previously overlooked patient population. This emerging therapeutic area represents a paradigm change in cancer treatment, offering new hope to patients while creating substantial market opportunities for innovative companies and...0 Σχόλια 0 Μοιράστηκε 297 Views 0 Προεπισκόπηση
-
AI and Genomics Revolutionize Liquid Biopsy TechnologiesThe global Liquid Biopsy Market is projected to expand from USD 3.8 billion in 2023 to USD 9.4 billion by 2032, growing at a robust CAGR of 10.7% during the forecast period (2024–2032). This rapid growth is fueled by increasing demand for non-invasive diagnostic methods, rising cancer incidence globally, and expanding applications of precision oncology. Liquid biopsy is transforming...0 Σχόλια 0 Μοιράστηκε 726 Views 0 Προεπισκόπηση
Αναζήτηση αποτελεσμάτων
Προωθημένο
English
Arabic
עברית
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)